CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 11; p. 1568
Main Authors Jakobsen, Mie K, Gjerstorff, Morten F
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 02.09.2020
Subjects
Animals
Antigens, Neoplasm - immunology
cancer immunotherapy
cancer/testis antigen
CAR T cell
DNA methyltransferase inhibitor
Humans
Immunology
Immunotherapy, Adoptive - adverse effects
Immunotherapy, Adoptive - methods
Neoplasms - diagnosis
Neoplasms - immunology
Neoplasms - therapy
T cell engineering
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Treatment Outcome
T cell engineering
DNA methyltransferase inhibitor
cancer/testis antigen
CAR T cell
cancer immunotherapy
Online AccessGet full text

Cover

Author Jakobsen, Mie K
Gjerstorff, Morten F
AuthorAffiliation 1 Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark , Odense , Denmark
3 Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital , Odense , Denmark
2 Department of Oncology, Odense University Hospital , Odense , Denmark
AuthorAffiliation_xml – name: 1 Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark , Odense , Denmark
– name: 3 Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital , Odense , Denmark
– name: 2 Department of Oncology, Odense University Hospital , Odense , Denmark
Author_xml – sequence: 1
  givenname: Mie K
  surname: Jakobsen
  fullname: Jakobsen, Mie K
  organization: Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark
– sequence: 2
  givenname: Morten F
  surname: Gjerstorff
  fullname: Gjerstorff, Morten F
  organization: Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32983080$$D View this record in MEDLINE/PubMed
BookMark eNpVkctr3DAQxkVISdI095yCj714o5dl61LYmj4CgULrnsVYGjkKfmwlu5D_vs7uNiRz0TCa-X3DfO_J6TiNSMg1oxshKn3rwzAsG0453VBWqOqEXDClZC44l6ev8nNyldIjXUNqIURxRs4F15WgFb0gn-vtz6zJa-z7rIbRYsyaB4ywe8oaiB3OYeyyX0v0YPHYcNtgmkPKtuMcOhzTB_LOQ5_w6vhekt9fvzT19_z-x7e7enufW6n4nDNWtKpQ3jJVtgq0AE-1bZEK5bi2TpRF4bwEqn2p0Fmg3rdSU680ZU6X4pLcHbhugkezi2GA-GQmCGZfmGJnIM7B9mhKcKxcBdE5KluroCos59g6hgIcL1bWpwNrt7TDKobjHKF_A337M4YH001_TSk156paAR-PgDj9WdaDmCEku14RRpyWZLiUSmvO9nvTQ6uNU0oR_YsMo-bZSbN30jw7afZOriM3r9d7Gfjvm_gHMBGcPg
CitedBy_id crossref_primary_10_1002_cac2_12330
crossref_primary_10_1002_1878_0261_13474
crossref_primary_10_1016_j_oraloncology_2021_105259
crossref_primary_10_3389_fonc_2023_1106434
crossref_primary_10_4049_jimmunol_2300049
crossref_primary_10_4049_jimmunol_2300618
crossref_primary_10_1007_s12032_023_02019_4
crossref_primary_10_1016_j_esmoop_2023_101618
crossref_primary_10_1002_cpz1_377
crossref_primary_10_3390_ijtm3030024
crossref_primary_10_1016_j_gene_2022_147082
crossref_primary_10_3389_fimmu_2023_1190883
crossref_primary_10_3390_cancers16071369
crossref_primary_10_3389_fimmu_2023_1118610
crossref_primary_10_3390_ijms242316872
crossref_primary_10_1158_1541_7786_MCR_22_0881
crossref_primary_10_3390_cancers16010124
crossref_primary_10_1111_aji_13639
Cites_doi 10.18632/oncotarget.4516
10.1038/bjc.2012.361
10.1038/mt.2013.185
10.1186/s13045-019-0793-7
10.1182/blood.V97.5.1508
10.3969/j.issn.2095-3941.2012.01.013
10.1158/1078-0432.CCR-15-0428
10.1038/nature12477
10.1038/s41586-019-1054-1
10.1016/j.molonc.2011.02.001
10.1158/2159-8290.CD-15-1020
10.1073/pnas.0907939106
10.1186/s40425-019-0678-x
10.1097/PPO.0000000000000157
10.3390/ijms21010204
10.1038/bcj.2014.14
10.1111/tan.12015
10.1056/NEJMoa1804980
10.1158/0008-5472.CAN-05-3840
10.1126/scitranslmed.aaa0984
10.1186/1471-2407-13-466
10.1038/nature22395
10.1016/j.cell.2017.03.036
10.1016/j.bbrc.2016.03.161
10.1002/ijc.22463
10.1002/ajh.20415
10.1097/PGP.0000000000000470
10.1038/s41467-019-12444-7
10.1056/NEJMoa1406498
10.1002/cam4.1601
10.1186/1471-2407-6-23
10.1158/1078-0432.CCR-19-1337
10.18632/oncotarget.1782
10.4049/jimmunol.1502024
10.1016/j.immuni.2013.07.002
10.1038/nrc1669
10.1371/journal.pone.0179501
10.1038/mto.2016.6
10.1038/leu.2013.355
10.2353/ajpath.2009.080893
10.18632/oncotarget.2505
10.1016/j.ymthe.2017.10.002
10.1158/0008-5472.CAN-05-3020
10.1056/NEJMra1706169
10.3389/fimmu.2019.02250
10.1056/NEJMoa1610497
10.1186/1471-2407-10-429
10.3390/ijms21020515
10.1038/s12276-018-0191-1
10.18632/oncotarget.20102
10.18632/oncotarget.19579
10.1016/j.cell.2015.07.056
10.1016/S0015-0282(97)81923-1
10.1038/s41571-019-0297-y
10.1002/ijc.11617
10.1158/0008-5472.CAN-04-1442
10.1007/s10147-016-0989-6
10.1093/neuonc/nou045
10.1200/JCO.2014.58.0225
10.1126/science.aaa1348
10.1056/NEJMoa1407222
10.1038/s41467-017-02630-w
10.3389/fonc.2018.00453
10.1038/s41598-019-49834-2
10.1111/cpr.12581
10.1158/1078-0432.CCR-06-1183
10.1172/JCI83416
10.18632/oncotarget.3324
10.1158/1078-0432.CCR-03-0813
10.1056/NEJMoa1709866
10.1128/MCB.19.11.7327
10.1182/blood-2009-11-249474
10.1126/scitranslmed.aar3342
10.1056/NEJMoa1707447
10.21873/anticanres.12937
10.1158/0008-5472.CAN-04-0454
10.18632/oncotarget.23009
10.1172/JCI92335
10.1038/s41591-018-0146-z
10.1177/002215540405200414
10.18632/oncotarget.4694
10.1111/j.1365-2141.2012.09225.x
10.1172/JCI131246
10.1038/mto.2016.23
ContentType Journal Article
Copyright Copyright © 2020 Jakobsen and Gjerstorff. 2020 Jakobsen and Gjerstorff
Copyright_xml – notice: Copyright © 2020 Jakobsen and Gjerstorff. 2020 Jakobsen and Gjerstorff
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fimmu.2020.01568
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
EndPage 1568
ExternalDocumentID oai_doaj_org_article_7ad17115edd04bc6a85c22ebd1e3ad25
10_3389_fimmu_2020_01568
32983080
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Novo Nordisk Foundation Center for Basic Metabolic Research
– fundername: Odense Universitetshospital
– fundername: Kræftens Bekæmpelse
– fundername: Velux Fonden
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CGR
CUY
CVF
DIK
EBS
ECM
EIF
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
KQ8
M48
M~E
NPM
OK1
PGMZT
RIG
RNS
RPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c462t-115b656fc167b6a93af09cbe036d29cd3755df4a09f76edca0ffb490f6901d973
IEDL.DBID RPM
ISSN 1664-3224
IngestDate Tue Oct 22 15:08:44 EDT 2024
Tue Sep 17 21:06:26 EDT 2024
Fri Oct 25 03:18:49 EDT 2024
Thu Sep 26 15:47:07 EDT 2024
Sat Sep 28 08:28:06 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords T cell engineering
DNA methyltransferase inhibitor
cancer/testis antigen
CAR T cell
cancer immunotherapy
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-115b656fc167b6a93af09cbe036d29cd3755df4a09f76edca0ffb490f6901d973
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Zong Sheng Guo, School of Medicine, University of Pittsburgh, United States
Edited by: Yoshihiko Hirohashi, Sapporo Medical University, Japan
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492268/
PMID 32983080
PQID 2446992197
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_7ad17115edd04bc6a85c22ebd1e3ad25
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7492268
proquest_miscellaneous_2446992197
crossref_primary_10_3389_fimmu_2020_01568
pubmed_primary_32983080
PublicationCentury 2000
PublicationDate 2020-09-02
PublicationDateYYYYMMDD 2020-09-02
PublicationDate_xml – month: 09
  year: 2020
  text: 2020-09-02
  day: 02
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2020
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Newick (B22) 2016; 3
Siebenkas (B83) 2017; 12
Gupta (B54) 2007; 120
O'Rourke (B18) 2017; 9
Shida (B65) 2015; 35
Mirandola (B55) 2017; 8
Lea (B58) 1997; 67
Sharma (B5) 2019; 10
Filley (B8) 2018; 8
Maude (B11) 2018; 378
Mao (B37) 2019; 12
Li (B52) 2010; 10
Maruta (B44) 2019; 9
Gjerstorff (B25) 2015; 6
Dadabayev (B61) 2005; 80
Guo (B35) 2006; 66
Kondo (B62) 2018; 38
Brown (B73) 2016; 375
Grizzi (B53) 2006; 6
Kunert (B34) 2016; 197
Wang (B41) 2016; 473
Yang (B87) 2014; 28
Marcinkowski (B68) 2019; 7
Snyder (B74) 2014; 371
Brown (B72) 2018; 26
Li (B82) 2014; 5
Schuster (B12) 2019; 380
Abbott (B21) 2020; 21
Lee (B49) 2004; 4
Cohen (B63) 2017; 8
Alexandrov (B76) 2013; 500
Ahmed (B19) 2015; 33
Pankov (B38) 2017; 8
da Cunha (B36) 2009; 106
Rafiq (B20) 2019; 17
Srdelic (B40) 2019; 38
Brown (B70) 2015; 21
Zhao (B7) 2019; 10
Gjerstorff (B56) 2013; 13
Fratta (B24) 2011; 5
Chiappinelli (B85) 2017; 169
Coral (B29) 2012; 107
Roulois (B86) 2015; 162
Simpson (B23) 2005; 5
Gjerstorff (B59) 2012; 80
Rizvi (B75) 2015; 348
Fukuyama (B66) 2006; 66
Zhang (B57) 2017; 9
De Smet (B26) 1999; 19
Chang (B42) 2017; 127
Hughes-Parry (B4) 2019; 21
Hegde (B80) 2019; 129
Silva (B50) 2007; 7
Neelapu (B13) 2017; 377
Sotillo (B15) 2015; 5
Sigalotti (B27) 2004; 64
Li (B30) 2014; 5
Maus (B43) 2016; 3
Orskov (B88) 2015; 6
Sadelain (B2) 2017; 545
Yang (B10) 2015; 21
Hegde (B81) 2016; 126
Grizzi (B60) 2004; 52
Orlando (B16) 2018; 24
Paret (B64) 2015; 6
Gang (B32) 2014; 4
Maude (B14) 2014; 371
Noh (B39) 2016; 21
Thaci (B69) 2014; 16
Kalos (B9) 2013; 39
Kahlon (B71) 2004; 64
Ye (B47) 2018; 7
Darvin (B1) 2018; 50
Rodig (B6) 2018; 10
Ding (B45) 2012; 9
Ormhoj (B79) 2019; 25
June (B3) 2018; 379
Toor (B33) 2012; 158
Goodyear (B31) 2010; 116
Hegde (B77) 2013; 21
Hamieh (B78) 2019; 568
Kershaw (B17) 2006; 12
Oberthuer (B46) 2004; 10
Lim (B48) 2001; 97
Chen (B67) 2019; 52
Luo (B84) 2018; 9
Straughn (B51) 2004; 108
Gjerstorff (B28) 2009; 175
References_xml – volume: 6
  start-page: 25356
  year: 2015
  ident: B64
  article-title: CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.4516
  contributor:
    fullname: Paret
– volume: 107
  start-page: 1116
  year: 2012
  ident: B29
  article-title: Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications
  publication-title: Br J Cancer.
  doi: 10.1038/bjc.2012.361
  contributor:
    fullname: Coral
– volume: 21
  start-page: 2087
  year: 2013
  ident: B77
  article-title: Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma
  publication-title: Mol Ther.
  doi: 10.1038/mt.2013.185
  contributor:
    fullname: Hegde
– volume: 12
  start-page: 106
  year: 2019
  ident: B37
  article-title: MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
  publication-title: J Hematol Oncol.
  doi: 10.1186/s13045-019-0793-7
  contributor:
    fullname: Mao
– volume: 97
  start-page: 1508
  year: 2001
  ident: B48
  article-title: Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma
  publication-title: Blood.
  doi: 10.1182/blood.V97.5.1508
  contributor:
    fullname: Lim
– volume: 9
  start-page: 73
  year: 2012
  ident: B45
  article-title: PRAME gene expression in acute leukemia and its clinical significance
  publication-title: Cancer Biol Med.
  doi: 10.3969/j.issn.2095-3941.2012.01.013
  contributor:
    fullname: Ding
– volume: 21
  start-page: 4062
  year: 2015
  ident: B70
  article-title: Bioactivity and safety of IL13Ralpha2-redirected chimeric antigen receptor CD8+ T cells in patients with recurrent glioblastoma
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-0428
  contributor:
    fullname: Brown
– volume: 500
  start-page: 415
  year: 2013
  ident: B76
  article-title: Signatures of mutational processes in human cancer
  publication-title: Nature.
  doi: 10.1038/nature12477
  contributor:
    fullname: Alexandrov
– volume: 568
  start-page: 112
  year: 2019
  ident: B78
  article-title: CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
  publication-title: Nature.
  doi: 10.1038/s41586-019-1054-1
  contributor:
    fullname: Hamieh
– volume: 5
  start-page: 164
  year: 2011
  ident: B24
  article-title: The biology of cancer testis antigens: putative function, regulation and therapeutic potential
  publication-title: Mol Oncol.
  doi: 10.1016/j.molonc.2011.02.001
  contributor:
    fullname: Fratta
– volume: 5
  start-page: 1282
  year: 2015
  ident: B15
  article-title: Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 Immunotherapy
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-15-1020
  contributor:
    fullname: Sotillo
– volume: 106
  start-page: 16752
  year: 2009
  ident: B36
  article-title: Bioinformatics construction of the human cell surfaceome
  publication-title: Proc Natl Acad Sci USA.
  doi: 10.1073/pnas.0907939106
  contributor:
    fullname: da Cunha
– volume: 7
  start-page: 229
  year: 2019
  ident: B68
  article-title: Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1
  publication-title: J Immunother Cancer.
  doi: 10.1186/s40425-019-0678-x
  contributor:
    fullname: Marcinkowski
– volume: 21
  start-page: 506
  year: 2015
  ident: B10
  article-title: Toxicities associated with adoptive T-Cell transfer for cancer
  publication-title: Cancer J.
  doi: 10.1097/PPO.0000000000000157
  contributor:
    fullname: Yang
– volume: 7
  start-page: 18
  year: 2007
  ident: B50
  article-title: PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses
  publication-title: Cancer Immun.
  contributor:
    fullname: Silva
– volume: 21
  start-page: 204
  year: 2019
  ident: B4
  article-title: The evolving protein engineering in the design of chimeric antigen receptor T cells
  publication-title: Int J Mol Sci.
  doi: 10.3390/ijms21010204
  contributor:
    fullname: Hughes-Parry
– volume: 4
  start-page: e197
  year: 2014
  ident: B32
  article-title: 5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies
  publication-title: Blood Cancer J
  doi: 10.1038/bcj.2014.14
  contributor:
    fullname: Gang
– volume: 80
  start-page: 523
  year: 2012
  ident: B59
  article-title: Limited SP17 expression within tumors diminishes its therapeutic potential
  publication-title: Tissue Antigens.
  doi: 10.1111/tan.12015
  contributor:
    fullname: Gjerstorff
– volume: 380
  start-page: 45
  year: 2019
  ident: B12
  article-title: Tisagenlecleucel in adult relapsed or refractory diffuse large B-Cell lymphoma
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1804980
  contributor:
    fullname: Schuster
– volume: 66
  start-page: 4922
  year: 2006
  ident: B66
  article-title: Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-3840
  contributor:
    fullname: Fukuyama
– volume: 9
  start-page: eaaa0984
  year: 2017
  ident: B18
  article-title: A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
  publication-title: Sci Transl Med.
  doi: 10.1126/scitranslmed.aaa0984
  contributor:
    fullname: O'Rourke
– volume: 13
  start-page: 466
  year: 2013
  ident: B56
  article-title: Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma
  publication-title: BMC Cancer.
  doi: 10.1186/1471-2407-13-466
  contributor:
    fullname: Gjerstorff
– volume: 545
  start-page: 423
  year: 2017
  ident: B2
  article-title: Therapeutic T cell engineering
  publication-title: Nature.
  doi: 10.1038/nature22395
  contributor:
    fullname: Sadelain
– volume: 169
  start-page: 361
  year: 2017
  ident: B85
  article-title: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses
  publication-title: Cell.
  doi: 10.1016/j.cell.2017.03.036
  contributor:
    fullname: Chiappinelli
– volume: 473
  start-page: 959
  year: 2016
  ident: B41
  article-title: MAGE-A1 promotes melanoma proliferation and migration through C-JUN activation
  publication-title: Biochem Biophys Res Commun.
  doi: 10.1016/j.bbrc.2016.03.161
  contributor:
    fullname: Wang
– volume: 120
  start-page: 1739
  year: 2007
  ident: B54
  article-title: Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer
  publication-title: Int J Cancer.
  doi: 10.1002/ijc.22463
  contributor:
    fullname: Gupta
– volume: 80
  start-page: 6
  year: 2005
  ident: B61
  article-title: Cancer immunotherapy targeting Sp17: when should the laboratory findings be translated to the clinics?
  publication-title: Am J Hematol.
  doi: 10.1002/ajh.20415
  contributor:
    fullname: Dadabayev
– volume: 38
  start-page: 59
  year: 2019
  ident: B40
  article-title: MAGE-A4 and MAGE-A1 Immunohistochemical Expression in High-grade Endometrial Cancer
  publication-title: Int J Gynecol Pathol.
  doi: 10.1097/PGP.0000000000000470
  contributor:
    fullname: Srdelic
– volume: 10
  start-page: 4553
  year: 2019
  ident: B5
  article-title: Rapid selection and identification of functional CD8(+) T cell epitopes from large peptide-coding libraries
  publication-title: Nat Commun.
  doi: 10.1038/s41467-019-12444-7
  contributor:
    fullname: Sharma
– volume: 371
  start-page: 2189
  year: 2014
  ident: B74
  article-title: Genetic basis for clinical response to CTLA-4 blockade in melanoma
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1406498
  contributor:
    fullname: Snyder
– volume: 7
  start-page: 3057
  year: 2018
  ident: B47
  article-title: Targeted photodynamic therapy of cancer using a novel gallium (III) tris (ethoxycarbonyl) corrole conjugated-mAb directed against cancer/testis antigens 83
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1601
  contributor:
    fullname: Ye
– volume: 6
  start-page: 23
  year: 2006
  ident: B53
  article-title: Sperm protein 17 is expressed in human nervous system tumours
  publication-title: BMC Cancer.
  doi: 10.1186/1471-2407-6-23
  contributor:
    fullname: Grizzi
– volume: 25
  start-page: 7046
  year: 2019
  ident: B79
  article-title: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-19-1337
  contributor:
    fullname: Ormhoj
– volume: 5
  start-page: 587
  year: 2014
  ident: B82
  article-title: Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.1782
  contributor:
    fullname: Li
– volume: 197
  start-page: 2541
  year: 2016
  ident: B34
  article-title: MAGE-C2-Specific TCRs combined with epigenetic drug-enhanced antigenicity yield robust and tumor-selective T cell responses
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.1502024
  contributor:
    fullname: Kunert
– volume: 39
  start-page: 49
  year: 2013
  ident: B9
  article-title: Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2013.07.002
  contributor:
    fullname: Kalos
– volume: 5
  start-page: 615
  year: 2005
  ident: B23
  article-title: Cancer/testis antigens, gametogenesis and cancer
  publication-title: Nat Rev Cancer.
  doi: 10.1038/nrc1669
  contributor:
    fullname: Simpson
– volume: 12
  start-page: e0179501
  year: 2017
  ident: B83
  article-title: Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
  publication-title: PLoS ONE.
  doi: 10.1371/journal.pone.0179501
  contributor:
    fullname: Siebenkas
– volume: 3
  start-page: 16006
  year: 2016
  ident: B22
  article-title: Chimeric antigen receptor T-cell therapy for solid tumors
  publication-title: Mol Ther Oncolytics.
  doi: 10.1038/mto.2016.6
  contributor:
    fullname: Newick
– volume: 28
  start-page: 1280
  year: 2014
  ident: B87
  article-title: Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
  publication-title: Leukemia.
  doi: 10.1038/leu.2013.355
  contributor:
    fullname: Yang
– volume: 175
  start-page: 314
  year: 2009
  ident: B28
  article-title: Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy
  publication-title: Am J Pathol.
  doi: 10.2353/ajpath.2009.080893
  contributor:
    fullname: Gjerstorff
– volume: 5
  start-page: 10791
  year: 2014
  ident: B30
  article-title: Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.2505
  contributor:
    fullname: Li
– volume: 26
  start-page: 31
  year: 2018
  ident: B72
  article-title: Optimization of IL13Ralpha2-Targeted Chimeric antigen receptor t cells for improved anti-tumor efficacy against glioblastoma
  publication-title: Mol Ther.
  doi: 10.1016/j.ymthe.2017.10.002
  contributor:
    fullname: Brown
– volume: 66
  start-page: 1105
  year: 2006
  ident: B35
  article-title: De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-3020
  contributor:
    fullname: Guo
– volume: 379
  start-page: 64
  year: 2018
  ident: B3
  article-title: Chimeric antigen receptor therapy
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMra1706169
  contributor:
    fullname: June
– volume: 10
  start-page: 2250
  year: 2019
  ident: B7
  article-title: Engineered T cell therapy for cancer in the clinic
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2019.02250
  contributor:
    fullname: Zhao
– volume: 9
  start-page: 454
  year: 2017
  ident: B57
  article-title: Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes
  publication-title: Am J Transl Res.
  contributor:
    fullname: Zhang
– volume: 375
  start-page: 2561
  year: 2016
  ident: B73
  article-title: Regression of glioblastoma after chimeric antigen receptor T-Cell therapy
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1610497
  contributor:
    fullname: Brown
– volume: 10
  start-page: 429
  year: 2010
  ident: B52
  article-title: Sperm protein 17 is highly expressed in endometrial and cervical cancers
  publication-title: BMC Cancer.
  doi: 10.1186/1471-2407-10-429
  contributor:
    fullname: Li
– volume: 21
  start-page: 515
  year: 2020
  ident: B21
  article-title: Finding the keys to the CAR: identifying novel target antigens for T cell redirection immunotherapies
  publication-title: Int J Mol Sci.
  doi: 10.3390/ijms21020515
  contributor:
    fullname: Abbott
– volume: 50
  start-page: 165
  year: 2018
  ident: B1
  article-title: Immune checkpoint inhibitors: recent progress and potential biomarkers
  publication-title: Exp Mol Med.
  doi: 10.1038/s12276-018-0191-1
  contributor:
    fullname: Darvin
– volume: 8
  start-page: 74378
  year: 2017
  ident: B55
  article-title: Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.20102
  contributor:
    fullname: Mirandola
– volume: 8
  start-page: 65917
  year: 2017
  ident: B38
  article-title: In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.19579
  contributor:
    fullname: Pankov
– volume: 162
  start-page: 961
  year: 2015
  ident: B86
  article-title: DNA-Demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts
  publication-title: Cell.
  doi: 10.1016/j.cell.2015.07.056
  contributor:
    fullname: Roulois
– volume: 67
  start-page: 355
  year: 1997
  ident: B58
  article-title: Autoimmunogenicity of the human sperm protein Sp17 in vasectomized men and identification of linear B cell epitopes
  publication-title: Fertil Steril.
  doi: 10.1016/S0015-0282(97)81923-1
  contributor:
    fullname: Lea
– volume: 17
  start-page: 147
  year: 2019
  ident: B20
  article-title: Engineering strategies to overcome the current roadblocks in CAR T cell therapy
  publication-title: Nat Rev Clin Oncol.
  doi: 10.1038/s41571-019-0297-y
  contributor:
    fullname: Rafiq
– volume: 108
  start-page: 805
  year: 2004
  ident: B51
  article-title: Expression of sperm protein 17 (Sp17) in ovarian cancer
  publication-title: Int J Cancer.
  doi: 10.1002/ijc.11617
  contributor:
    fullname: Straughn
– volume: 64
  start-page: 9167
  year: 2004
  ident: B27
  article-title: Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-1442
  contributor:
    fullname: Sigalotti
– volume: 21
  start-page: 875
  year: 2016
  ident: B39
  article-title: MAGE-A1-6 expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes
  publication-title: Int J Clin Oncol.
  doi: 10.1007/s10147-016-0989-6
  contributor:
    fullname: Noh
– volume: 16
  start-page: 1304
  year: 2014
  ident: B69
  article-title: Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
  publication-title: Neuro Oncol.
  doi: 10.1093/neuonc/nou045
  contributor:
    fullname: Thaci
– volume: 33
  start-page: 1688
  year: 2015
  ident: B19
  article-title: Human epidermal growth factor Receptor 2 (HER2) -specific chimeric antigen receptor-modified T cells for the immunotherapy of HER2-Positive sarcoma
  publication-title: J Clin Oncol.
  doi: 10.1200/JCO.2014.58.0225
  contributor:
    fullname: Ahmed
– volume: 348
  start-page: 124
  year: 2015
  ident: B75
  article-title: Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
  publication-title: Science.
  doi: 10.1126/science.aaa1348
  contributor:
    fullname: Rizvi
– volume: 371
  start-page: 1507
  year: 2014
  ident: B14
  article-title: Chimeric antigen receptor T cells for sustained remissions in leukemia
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1407222
  contributor:
    fullname: Maude
– volume: 9
  start-page: 248
  year: 2018
  ident: B84
  article-title: DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
  publication-title: Nat Commun.
  doi: 10.1038/s41467-017-02630-w
  contributor:
    fullname: Luo
– volume: 8
  start-page: 453
  year: 2018
  ident: B8
  article-title: CART immunotherapy: development, success, and translation to malignant gliomas and other solid tumors
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2018.00453
  contributor:
    fullname: Filley
– volume: 9
  start-page: 13293
  year: 2019
  ident: B44
  article-title: Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy
  publication-title: Sci Rep.
  doi: 10.1038/s41598-019-49834-2
  contributor:
    fullname: Maruta
– volume: 52
  start-page: e12581
  year: 2019
  ident: B67
  article-title: Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling
  publication-title: Cell Prolif.
  doi: 10.1111/cpr.12581
  contributor:
    fullname: Chen
– volume: 12
  start-page: 6106
  year: 2006
  ident: B17
  article-title: A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-06-1183
  contributor:
    fullname: Kershaw
– volume: 126
  start-page: 3036
  year: 2016
  ident: B81
  article-title: Tandem CAR T cells targeting HER2 and IL13Ralpha2 mitigate tumor antigen escape
  publication-title: J Clin Invest.
  doi: 10.1172/JCI83416
  contributor:
    fullname: Hegde
– volume: 6
  start-page: 9612
  year: 2015
  ident: B88
  article-title: Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.3324
  contributor:
    fullname: Orskov
– volume: 10
  start-page: 4307
  year: 2004
  ident: B46
  article-title: The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-03-0813
  contributor:
    fullname: Oberthuer
– volume: 378
  start-page: 439
  year: 2018
  ident: B11
  article-title: Tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1709866
  contributor:
    fullname: Maude
– volume: 19
  start-page: 7327
  year: 1999
  ident: B26
  article-title: DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter
  publication-title: Mol Cell Biol.
  doi: 10.1128/MCB.19.11.7327
  contributor:
    fullname: De Smet
– volume: 116
  start-page: 1908
  year: 2010
  ident: B31
  article-title: Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia
  publication-title: Blood.
  doi: 10.1182/blood-2009-11-249474
  contributor:
    fullname: Goodyear
– volume: 10
  start-page: eaar3342
  year: 2018
  ident: B6
  article-title: MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
  publication-title: Sci Transl Med.
  doi: 10.1126/scitranslmed.aar3342
  contributor:
    fullname: Rodig
– volume: 377
  start-page: 2531
  year: 2017
  ident: B13
  article-title: Axicabtagene ciloleucel CAR T-Cell therapy in refractory large B-Cell lymphoma
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1707447
  contributor:
    fullname: Neelapu
– volume: 4
  start-page: 13
  year: 2004
  ident: B49
  article-title: Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer
  publication-title: Cancer Immun.
  contributor:
    fullname: Lee
– volume: 38
  start-page: 5923
  year: 2018
  ident: B62
  article-title: Detection of KK-LC-1 protein, a cancer/testis antigen, in patients with breast cancer
  publication-title: Anticancer Res.
  doi: 10.21873/anticanres.12937
  contributor:
    fullname: Kondo
– volume: 64
  start-page: 9160
  year: 2004
  ident: B71
  article-title: Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-0454
  contributor:
    fullname: Kahlon
– volume: 8
  start-page: 113373
  year: 2017
  ident: B63
  article-title: Cell-surface marker discovery for lung cancer
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.23009
  contributor:
    fullname: Cohen
– volume: 127
  start-page: 2705
  year: 2017
  ident: B42
  article-title: A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
  publication-title: J Clin Invest.
  doi: 10.1172/JCI92335
  contributor:
    fullname: Chang
– volume: 24
  start-page: 1504
  year: 2018
  ident: B16
  article-title: Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
  publication-title: Nat Med.
  doi: 10.1038/s41591-018-0146-z
  contributor:
    fullname: Orlando
– volume: 52
  start-page: 549
  year: 2004
  ident: B60
  article-title: Sperm protein 17 is expressed in human somatic ciliated epithelia
  publication-title: J Histochem Cytochem.
  doi: 10.1177/002215540405200414
  contributor:
    fullname: Grizzi
– volume: 6
  start-page: 15772
  year: 2015
  ident: B25
  article-title: Oncogenic cancer/testis antigens: prime candidates for immunotherapy
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.4694
  contributor:
    fullname: Gjerstorff
– volume: 158
  start-page: 700
  year: 2012
  ident: B33
  article-title: Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity
  publication-title: Br J Haematol.
  doi: 10.1111/j.1365-2141.2012.09225.x
  contributor:
    fullname: Toor
– volume: 35
  start-page: 3575
  year: 2015
  ident: B65
  article-title: Frequent high expression of kita-kyushu lung cancer Antigen-1 (KK-LC-1) in gastric cancer
  publication-title: Anticancer Res.
  contributor:
    fullname: Shida
– volume: 129
  start-page: 3464
  year: 2019
  ident: B80
  article-title: Tandem CAR T cells targeting HER2 and IL13Ralpha2 mitigate tumor antigen escape
  publication-title: J Clin Invest.
  doi: 10.1172/JCI131246
  contributor:
    fullname: Hegde
– volume: 3
  start-page: 1
  year: 2016
  ident: B43
  article-title: An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity
  publication-title: Mol Ther Oncolytics.
  doi: 10.1038/mto.2016.23
  contributor:
    fullname: Maus
SSID ssj0000493335
Score 2.3886242
SecondaryResourceType review_article
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1568
SubjectTerms Animals
Antigens, Neoplasm - immunology
cancer immunotherapy
cancer/testis antigen
CAR T cell
DNA methyltransferase inhibitor
Humans
Immunology
Immunotherapy, Adoptive - adverse effects
Immunotherapy, Adoptive - methods
Neoplasms - diagnosis
Neoplasms - immunology
Neoplasms - therapy
T cell engineering
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Treatment Outcome
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NSyQxEA0iCF7EVddt3ZUWvHjonXSSTjrHcVBE0IO24C3kk1W0lfk4-O-3kowyI4IXr92BLt4LXa9I5RVCR1RDVsfGVbyVbQWS2lUyYFNJyDbE1S7U6d7a5RU_v2UXd83dwqiv2BOW7YEzcAOhXS1AtnjnMDOW67axhHjjak-1I9m9FMuFYuoh615KaZPPJaEKk4Nw__Q0g3qQ4L_x9nC7lIeSXf9nGvNjq-RC7jnbRBtz0VgOc7A_0Irvt9BaHiP5uo1ORsPrsqtG_vGxHEUWx2WXzQLKLjV6Q3oqb2bjoK2fLxh00V1jUg77abTjnOyg27PTbnRezWcjVJZxMq0AEQNSLNiaC8O1pDpgaY2HhOSItI6KpnGBaSyD4BC-xiEYJnGIA6icFPQnWu2fe_8Llbw1wgbf1NwbhmnQzGBKKONeuNoGXKDjN6TUS7bAUFA6RFRVQlVFVFVCtUAnEcr3ddG8Oj0AStWcUvUVpQU6fCNCwWaPJxi698-ziQItwqWEn6wo0G4m5v1TlMiWgv4tkFiibCmW5Tf9_b9kqC2YBBXa7n1H8PtoPcKR2tDIb7Q6Hc_8H9AtU3OQtuh_1_DsZg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB1BEagXxDfhS0HiwiGtYzt2fEBou6KqkOAAWak3y45tKNpmaXZXav89YydbumhPXBNbdt7YmTfy-A3AO2bQqxPrClGrukBK7QoViC0UehvqShfKdG_ty1dxMuOfT6vTv9ejRwCXO0O7WE9q1s8PLi-uPuKG_xAjTvS3h-Hs_HyNoR4lB_FicH0b7lCOcXpM5BvJ_q-BCzPGquGscmfHfbjHqKpZEom84aaSmv8uCvpvJuUN13T8AO6PnDKfDIvgIdzy3SO4O1SZvHoMR9PJt7wppn4-z6fRyH3eDFoCeZPywNF75d_XfTCtHxscNlF8Y5lPulVU61w-gdnxp2Z6UoylE4qWC7oqkOdZZGqhLYW0wihmAlGt9eivHFWtY7KqXOCGqCAFTt-QECxXJMT6VE5J9hT2ukXnn0Muaivb4KtSeMsJC4ZbwijjwktXtoFk8H6DlP49KGRojCwiwDoBrCPAOgGcwVGE8rpd1LZODxb9Dz1uFS2NKyV-gHeOcNsKU1ctpd660jPjaJXB240hNO6FeMBhOr9YLzVSFaEU_oNlBs8Gw1wPtTFsBnLLZFtz2X7Tnf1MetuSKySp9Yv_7vkS9iMGKTWNvoK9Vb_2r5HLrOybtET_AMoK89o
  priority: 102
  providerName: Scholars Portal
Title CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
URI https://www.ncbi.nlm.nih.gov/pubmed/32983080
https://search.proquest.com/docview/2446992197
https://pubmed.ncbi.nlm.nih.gov/PMC7492268
https://doaj.org/article/7ad17115edd04bc6a85c22ebd1e3ad25
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJoNBL6btu0-BCLz14LUuyZB03pmkobCmtA3szerYbdr1hH4f--4xkO-yWnnrRwZax_M3g-QaNvkHoI1UQ1bG2Ga9klQGltpn0WGcSog2xhfVFPLc2-8avb9jXeTk_QeV4FiYW7Ru9mHTL1aRb_I61lXcrk491Yvn3WS2YBNZQ5afoFBz0IEW_7SkvpbTstyQhAZO5X6xWe0gFCZ6Eg8OhRR8lsqJRC_IgGkXR_n8xzb8LJg8i0NVT9GSgjum0X-IzdOK65-hR30zyzwt0WU9_pE1Wu-UyrYMtN2nTSwakTSz3hiCV_txvvDJumJA3QWNjm067XRDl3L5EN1efm_o6GzokZIZxssuAzmkgZN4UXGiuJFUeS6MdhCVLpLFUlKX1TGHpBYflK-y9ZhL70IbKSkFfobNu3bk3KOWVFsa7suBOM0y9YhpTQhl3whbG4wR9GpFq73ohjBYSiABwGwFuA8BtBDhBlwHKh3lBwjpeWG9-tYMhW6FsIeADnLWYacNVVRpCnLaFo8qSMkEfRkO04PJhH0N1br3ftsBIuJTwqxUJet0b5uFVo2ETJI5MdrSW4zvgZVFWe_Cqt__95Dv0OGAQK9DIOTrbbfbuPVCWnb6IqT6MX-YFjDNWXUSnvQe-_-6Y
link.rule.ids 230,315,730,783,787,867,888,2109,24330,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaWRQguvB_hGSQuHNI4sWPHx27EqsB2hSCL9mb5CYU2XbXJAX49tpOs2hUXuMaOYs9nZ76Rx98A8AYJ59Wh1AkpWZk4Sq0TZqFMmPM2uc60zcK9tfkpmZ3hD-fF-QEoxrswIWlfycWkWa4mzeJ7yK28WKl0zBNLP80ripljDWV6DVx3-xXinSD9R096EUJFfyjpQjCW2sVq1blgMIcTf3XYF-lDOStRUIPc8UdBtv9vXPNqyuSODzq-A76Oo-9TT35OulZO1O8rwo7_PL274PbASuNp33wPHJjmPrjR16n89QAcVdPPcZ1UZrmMK79MNnHdqxHEdcgkd_4v_tJtrFBm6JDWXr5jG0-b1ut9bh-Cs-N3dTVLhuILicIkbxPHFKXjelZlhEoiGBIWMiWN83g6Z0ojWhTaYgGZpcTZRUBrJWbQ-gpXmlH0CBw268Y8ATEpJVXWFBkxEkNkBZYQ5QgTQ3WmLIzA2xECftFrbHAXm3jkeECOe-R4QC4CRx6jy35eHTs8WG--8cGInAqdUTcBozXEUhFRFirPjdSZQULnRQRejwhzt5v8EYlozLrbckd2CGPuL04j8LhH_PJT44qJAN1bC3tj2W9xCAfF7gHRp__95itwc1bPT_jJ-9OPz8Atb4-Q6JY_B4ftpjMvHDNq5cuwD_4AMLIN4w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jj9MwGLVgEIgL-xLWIHHhkMaxEzs-dgLVsMxoBBlpxMXyCoU2rdrkAL8e20lG7YjTXBNHif3sfO-Tn98HwFssXFSHUiekZGXiKLVOmIUyYS7aIJ1pm4Vza8cn5Ogs_3RenO-U-gqifSXnk2axnDTzn0FbuV6qdNSJpafHFc2ZYw1lutY2vQ5uuDULyU6i_qsnvhjjot-YdGkYS-18uexcQojgxB8f9oX6MGIlDo6QOzEpWPf_j29elk3uxKHZXfB97EEvP_k96Vo5UX8vmTteqYv3wJ2BncbTvsl9cM00D8DNvl7ln4fgsJp-jeukMotFXPnpsonr3pUgroOi3MXB-Fu3sUKZoUFaexuPbTxtWu_7uX0EzmYf6uooGYowJConqE0cY5SO81mVESqJYFhYyJQ0LvJpxJTGtCi0zQVklhI3NgJaK3MGra90pRnFj8FBs2rMUxCTUlJlTZERI3OIrcglxAjnxFCdKQsj8G6Ega97rw3uchSPHg_ocY8eD-hF4NDjdNHOu2SHC6vNDz4MJKdCZ9R1wGgNc6mIKAuFkJE6M1hoVETgzYgyd6vKb5WIxqy6LXekhzDm_uY0Ak961C9eNc6aCNC9-bD3Lft3HMrBuXtA9dmVn3wNbp2-n_EvH08-Pwe3_XAEvRt6AQ7aTWdeOoLUyldhKfwDpfoQYw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CAR+T-Cell+Cancer+Therapy+Targeting+Surface+Cancer%2FTestis+Antigens&rft.jtitle=Frontiers+in+immunology&rft.au=Jakobsen%2C+Mie+K.&rft.au=Gjerstorff%2C+Morten+F.&rft.date=2020-09-02&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=11&rft_id=info:doi/10.3389%2Ffimmu.2020.01568&rft_id=info%3Apmid%2F32983080&rft.externalDBID=PMC7492268
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon